See more : AgriFORCE Growing Systems Ltd. (AGRIW) Income Statement Analysis – Financial Results
Complete financial analysis of Oxford Lane Capital Corp. (OXLCP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Oxford Lane Capital Corp., a leading company in the Asset Management industry within the Financial Services sector.
You may be interested
- The Kroger Co. (0JS2.L) Income Statement Analysis – Financial Results
- PTT Oil and Retail Business Public Company Limited (OR.BK) Income Statement Analysis – Financial Results
- Spyre Therapeutics, Inc. (SYRE) Income Statement Analysis – Financial Results
- NanoSphere Health Sciences Inc. (NSHSF) Income Statement Analysis – Financial Results
- The GPT Group (GPTGF) Income Statement Analysis – Financial Results
Oxford Lane Capital Corp. (OXLCP)
About Oxford Lane Capital Corp.
Oxford Lane Capital Corp. is a close ended fund launched and managed by Oxford Lane Management LLC. It invests in fixed income securities. The fund primarily invests in securitization vehicles which in turn invest in senior secured loans made to companies whose debt is rated below investment grade or is unrated. Oxford Lane Capital Corp was formed on June 9, 2010 and is domiciled in the United States.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 290.64M | -158.43M | 130.15M | 293.35M | -288.16M | -18.57M | 40.42M | 107.41M | -83.46M | 5.95M | 25.25M | 11.60M | 5.01M | 520.00K |
| Cost of Revenue | 77.49M | 65.59M | 54.45M | 32.12M | 31.63M | 23.62M | 19.38M | 14.59M | 15.10M | 0.00 | 0.00 | 3.87M | 1.21M | 140.00K |
| Gross Profit | 213.15M | -224.02M | 75.69M | 261.23M | -319.79M | -42.20M | 21.04M | 92.82M | -98.56M | 5.95M | 25.25M | 7.73M | 3.80M | 380.00K |
| Gross Profit Ratio | 73.34% | 141.40% | 58.16% | 89.05% | 110.98% | 227.20% | 52.05% | 86.42% | 118.09% | 100.00% | 100.00% | 66.64% | 75.85% | 73.08% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 5.33M | 4.45M | 3.91M | 3.22M | 2.80M | 2.27M | 2.28M | 2.10M | 2.23M | 2.51M | 2.52M | 1.80M | 1.17M | 260.00K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.33M | 4.45M | 3.91M | 3.22M | 2.80M | 2.27M | 2.28M | 2.10M | 2.23M | 2.51M | 2.52M | 1.80M | 1.17M | 260.00K |
| Other Expenses | 0.00 | -315.74M | 361.97K | 201.41K | 176.24K | 140.67K | 136.90K | 108.62K | 83.59K | 109.11K | 69.76K | 0.00 | 0.00 | -10.00K |
| Operating Expenses | 11.55M | 12.86M | 4.27M | 3.42M | 2.97M | 2.41M | 2.42M | 2.21M | 2.32M | 2.62M | 2.59M | 1.80M | 1.17M | 250.00K |
| Cost & Expenses | 22.68M | 12.86M | 4.27M | 3.42M | 2.97M | 2.41M | 2.42M | 2.21M | 2.32M | 2.62M | 2.59M | 5.67M | 2.38M | 390.00K |
| Interest Income | 15.31M | 7.25M | 3.95M | 6.12M | 3.74M | 1.40M | 1.60M | 1.05M | 1.04M | 1.45M | 23.01M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 32.86M | 31.81M | 22.08M | 16.28M | 15.48M | 15.05M | 13.40M | 11.71M | 14.81M | 10.66M | 4.50M | 18.39M | 1.79M | 0.00 |
| Depreciation & Amortization | 1.00 | 228.49K | 236.56K | 206.30K | 171.86K | 161.14K | 52.52K | 22.82K | 14.81M | 10.66M | 4.50M | 36.78M | 3.58M | -80.00K |
| EBITDA | 267.96M | -171.29M | 147.96M | 306.21M | -275.65M | 0.00 | 39.72M | 116.91M | -70.97M | 13.99M | 27.16M | 42.70M | 6.21M | 40.00K |
| EBITDA Ratio | 92.20% | 108.11% | 113.68% | 104.38% | 95.66% | 31.93% | 127.17% | 108.85% | 85.03% | 235.18% | 107.55% | 368.10% | 123.95% | 7.69% |
| Operating Income | 267.96M | -171.29M | 147.96M | 306.21M | -275.65M | -5.93M | 51.41M | 116.91M | -85.78M | 3.33M | 22.66M | 5.92M | 2.63M | 120.00K |
| Operating Income Ratio | 92.20% | 108.11% | 113.68% | 104.38% | 95.66% | 31.93% | 127.17% | 108.85% | 102.77% | 56.00% | 89.73% | 51.03% | 52.50% | 23.08% |
| Total Other Income/Expenses | -32.86M | -31.81M | -22.08M | -16.28M | -15.48M | 0.00 | -1.71M | 14.59M | 0.00 | 0.00 | 0.00 | 18.39M | 1.79M | -40.00K |
| Income Before Tax | 235.11M | -171.29M | 125.88M | 289.93M | -291.13M | -20.98M | 38.01M | 105.20M | -85.78M | 3.33M | 22.66M | 24.31M | 4.42M | 80.00K |
| Income Before Tax Ratio | 80.89% | 108.11% | 96.72% | 98.83% | 101.03% | 112.97% | 94.02% | 97.94% | 102.77% | 56.00% | 89.73% | 209.57% | 88.22% | 15.38% |
| Income Tax Expense | 0.00 | -32.03M | -236.56K | -206.30K | -171.86K | -161.14K | -52.52K | -22.82K | -14.81M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 235.11M | -171.29M | 125.88M | 289.93M | -291.13M | -20.98M | 38.01M | 105.20M | -85.78M | 3.33M | 22.66M | 24.31M | 4.42M | 80.00K |
| Net Income Ratio | 80.89% | 108.11% | 96.72% | 98.83% | 101.03% | 112.97% | 94.02% | 97.94% | 102.77% | 56.00% | 89.73% | 209.57% | 88.22% | 15.38% |
| EPS | 1.12 | -1.14 | 1.20 | 3.14 | -4.14 | -0.51 | 1.49 | 5.41 | -4.64 | 0.23 | 1.49 | 1.55 | 0.28 | 0.01 |
| EPS Diluted | 1.12 | -1.14 | 1.20 | 3.14 | -4.14 | -0.51 | 1.49 | 5.41 | -4.64 | 0.23 | 1.49 | 1.55 | 0.28 | 0.01 |
| Weighted Avg Shares Out | 209.92M | 150.25M | 104.90M | 92.34M | 70.32M | 41.14M | 25.51M | 19.45M | 18.49M | 14.48M | 15.24M | 15.70M | 15.70M | 15.70M |
| Weighted Avg Shares Out (Dil) | 209.92M | 150.25M | 104.90M | 92.34M | 70.32M | 41.14M | 25.51M | 19.45M | 18.49M | 14.48M | 15.24M | 15.70M | 15.70M | 15.70M |
4 Funds Bought In August, Mixture Of Opportunity And Speculation
We see the 5th month of gains for the broader indexes and reach new all-time highs on the SP500 and continued new highs for NDX.
The Chemist's Quality Closed-End Fund Report: August 2020
Only funds with coverage >100% are considered. Top lists of discount, yield, DxY and DxYxZ are given.
Weekly Closed-End Fund Roundup: August 30, 2020
13 out of 23 CEF sectors positive on price and 16 out of 23 sectors positive on NAV last week. Commodities lead while MLPs lag.
Weekly Closed-End Fund Roundup: August 23, 2020
8 out of 23 CEF sectors positive on price and 7 out of 23 sectors positive on NAV last week. Taxable munis gain while MLPs lag.
Weekly Closed-End Fund Roundup: MAV Boosts Again (August 16, 2020)
13 out of 23 CEF sectors positive on price and 9 out of 23 sectors positive on NAV last week. MAV, a holding in two Income Lab portfolios, boosts its distribution again.
What We Hold Across The CLO Equity Capital Structures
CLO equity funds offer the highest yields across the income investment space. However, this comes at the expense of NAV transparency.
The Retiree's Dividend Portfolio - Jane's July Update: Resilient Dividends
Jane's retirement accounts generated a total of $2,028.65 of dividend income for July 2020 vs. $1,988.24 of dividend income for July of 2019.
Weekly Closed-End Fund Roundup: August 9, 2020
23 out of 23 CEF sectors positive on price and 23 out of 23 sectors positive on NAV last week. Commodities continue to rally, energy also puts in a strong performance.
Oxford Lane Capital Corp. (OXLC) CEO Jonathan Cohen on Q1 2021 Results - Earnings Call Transcript
Oxford Lane Capital Corp. (NASDAQ:OXLC) Q1 2021 Earnings Conference Call July 31, 2020 09:00 AM ET Company Participants Jonathan Cohen - Chief Executive Officer Saul Rosenthal - President Bruce Rubin - Chief Financial Officer Deep Maji - Senior Managing Director,...
The Chemist's Closed-End Fund Report: July 2020
CEF discounts remain significantly wider than their historical average, indicating attractive valuations.
Source: https://incomestatements.info
Category: Stock Reports